{
    "2019-12-13": [
        [
            {
                "time": "",
                "original_text": "控股股东上实集团增持上海医药(02607) 865.79万股，每股作价14.66港元",
                "features": {
                    "keywords": [
                        "控股股东",
                        "上实集团",
                        "增持",
                        "上海医药",
                        "865.79万股",
                        "14.66港元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【权益变动】上海医药(02607-HK)获控股股东上实集团增持865.79万股",
                "features": {
                    "keywords": [
                        "权益变动",
                        "上海医药",
                        "控股股东",
                        "上实集团",
                        "增持",
                        "865.79万股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "90后成线上购买主力: 医药保健品前三季进口增35.5%",
                "features": {
                    "keywords": [
                        "90后",
                        "线上购买",
                        "医药保健品",
                        "进口增长",
                        "35.5%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "保健品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}